Eledon Pharmaceuticals, Inc.
ELDN • NASDAQ
Eledon Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David-Alexandre C. Gros, with a market cap of $214.7M.
CEODavid-Alexandre C. Gros
Next Earnings
Upcoming earnings announcement for Eledon Pharmaceuticals, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.23
Earnings History
Past 12 earnings reports for Eledon Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.10Est: -$0.20 | +50.0% | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.21Est: -$0.24 | +12.5% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.13Est: -$0.23 | +43.5% | - | — | 10-Q/A |
| May 14, 2025 | Q1 2025 | -$0.08Est: -$0.28 | +71.4% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.64Est: -$0.34 | -88.2% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.32Est: -$0.30 | -6.7% | - | — | 10-Q |
| Aug 18, 2024 | Q2 2024 | -$1.06Est: -$0.30 | -253.3% | - | — | 10-Q/A |
| May 9, 2024 | Q1 2024 | -$0.34Est: -$0.39 | +12.8% | - | — | — |
| Mar 28, 2024 | Q4 2023 | -$0.32Est: -$0.39 | +17.9% | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.35Est: -$0.50 | +30.0% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.40Est: -$0.46 | +13.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.75Est: -$0.60 | -25.0% | - | — | — |